GlauCanna Overview

  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

GlauCanna General Information


Provider of medical marijuana intended to treat glaucoma patients. The company's marijuana is focused on glaucoma condition which is treated with cannabis oil, that has been shown to reduce intraocular pressure and the disease's painful symptoms, enabling doctors to treat individuals suffering from glaucoma.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • Punta Gorda, FL
  • United States
+1 (941) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlauCanna Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 13-Apr-2017 Completed Startup

GlauCanna Investors (1)

To view GlauCanna‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Mentor Capital Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial